🇺🇸 SELLAS Life Sciences Group, Inc.SLS
Get SELLAS Life Sciences Group, Inc. filings on Telegram the moment they are published.
Follow SELLAS Life Sciences Group, Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 7.01, 8.01, 9.01
Overview: Announced positive Phase 3 REGAL trial results for galinpepimut-S, showing a 41% reduction in death risk and median overall survival of 24.0 months.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest